First Horizon Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Sell |
12,677
-2,262
| -15% | -$255K | 0.04% | 221 |
|
|
2025
Q1 | $1.67M | Buy |
14,939
+494
| +3% | +$52.6K | 0.05% | 212 |
|
|
2024
Q4 | $1.41M | Buy |
14,445
+56
| +0.4% | +$5.97K | 0.04% | 224 |
|
|
2024
Q3 | $1.66M | Buy |
14,389
+323
| +2% | +$36.6K | 0.05% | 217 |
|
|
2024
Q2 | $1.5M | Buy |
14,066
+2,439
| +21% | +$245K | 0.05% | 220 |
|
|
2024
Q1 | $1.12M | Sell |
11,627
-48
| -0.4% | -$4.92K | 0.03% | 234 |
|
|
2023
Q4 | $1.18M | Sell |
11,675
-287
| -2% | -$27.7K | 0.04% | 234 |
|
|
2023
Q3 | $1.22M | Sell |
11,962
-10
| -0.1% | -$1.01K | 0.04% | 226 |
|
|
2023
Q2 | $1.21M | Buy |
11,972
+103
| +0.9% | +$10.3K | 0.04% | 242 |
|
|
2023
Q1 | $1.09M | Sell |
11,869
-283
| -2% | -$24.7K | 0.04% | 248 |
|
|
2022
Q4 | $1.1M | Sell |
12,152
-1,826
| -13% | -$154K | 0.04% | 249 |
|
|
2022
Q3 | $1.06M | Sell |
13,978
-892
| -6% | -$73.9K | 0.04% | 243 |
|
|
2022
Q2 | $1.26M | Sell |
14,870
-230
| -2% | -$20.2K | 0.04% | 240 |
|
|
2022
Q1 | $1.32M | Sell |
15,100
-1,461
| -9% | -$126K | 0.07% | 209 |
|
|
2021
Q4 | $1.45M | Sell |
16,561
-2,543
| -13% | -$211K | 0.04% | 250 |
|
|
2021
Q3 | $1.56M | Buy |
19,104
+11,912
| +166% | +$1.07M | 0.05% | 239 |
|
|
2021
Q2 | $655K | Sell |
7,192
-6,923
| -49% | -$616K | 0.04% | 232 |
|
|
2021
Q1 | $1.21M | Sell |
14,115
-63,482
| -82% | -$5.7M | 0.07% | 177 |
|
|
2020
Q4 | $7.33M | Buy |
77,597
+3,298
| +4% | +$288K | 0.49% | 61 |
|
|
2020
Q3 | $6.46M | Buy |
74,299
+2,963
| +4% | +$257K | 0.48% | 66 |
|
|
2020
Q2 | $6.23M | Buy |
71,336
+5,207
| +8% | +$449K | 0.49% | 62 |
|
|
2020
Q1 | $5.45M | Buy |
66,129
+5,869
| +10% | +$524K | 0.51% | 60 |
|
|
2019
Q4 | $5.71M | Buy |
60,260
+3,342
| +6% | +$300K | 0.42% | 70 |
|
|
2019
Q3 | $4.95M | Buy |
56,918
+763
| +1% | +$68.5K | 0.39% | 78 |
|
|
2019
Q2 | $5.13M | Sell |
56,155
-1,255
| -2% | -$106K | 0.4% | 73 |
|
|
2019
Q1 | $4.95M | Buy |
57,410
+6,030
| +12% | +$484K | 0.4% | 69 |
|
|
2018
Q4 | $3.95M | Buy |
51,380
+5,132
| +11% | +$399K | 0.35% | 71 |
|
|
2018
Q3 | $3.57M | Buy |
46,248
+2,125
| +5% | +$157K | 0.28% | 100 |
|
|
2018
Q2 | $2.98M | Buy |
44,123
+2,609
| +6% | +$180K | 0.25% | 114 |
|
|
2018
Q1 | $3.01M | Buy |
41,514
+2,886
| +7% | +$220K | 0.29% | 96 |
|
|
2017
Q4 | $2.94M | Buy |
38,628
+1,775
| +5% | +$134K | 0.28% | 97 |
|
|
2017
Q3 | $2.84M | Sell |
36,853
-212
| -0.6% | -$16K | 0.29% | 96 |
|
|
2017
Q2 | $2.78M | Buy |
37,065
+1,973
| +6% | +$140K | 0.3% | 95 |
|
|
2017
Q1 | $2.38M | Buy |
35,092
+6,644
| +23% | +$443K | 0.27% | 99 |
|
|
2016
Q4 | $1.97M | Hold |
28,448
| – | – | 0.25% | 111 |
|
|
2016
Q3 | $1.97M | Sell |
28,448
-1,719
| -6% | -$125K | 0.25% | 111 |
|
|
2016
Q2 | $2.23M | Buy |
30,167
+1,076
| +4% | +$74.3K | 0.3% | 102 |
|
|
2016
Q1 | $1.9M | Buy |
29,091
+2,431
| +9% | +$165K | 0.21% | 110 |
|
|
2015
Q4 | $2.05M | Sell |
26,660
-3,331
| -11% | -$265K | 0.36% | 89 |
|
|
2015
Q3 | $2.47M | Sell |
29,991
-4,705
| -14% | -$419K | 0.38% | 95 |
|
|
2015
Q2 | $3.06M | Sell |
34,696
-2,119
| -6% | -$194K | 0.44% | 87 |
|
|
2015
Q1 | $3.31M | Sell |
36,815
-1,858
| -5% | -$165K | 0.48% | 76 |
|
|
2014
Q4 | $3.22M | Buy |
38,673
+267
| +0.7% | +$22.1K | 0.5% | 68 |
|
|
2014
Q3 | $3.24M | Buy |
38,406
+1,055
| +3% | +$85.4K | 0.51% | 67 |
|
|
2014
Q2 | $2.94M | Buy |
37,351
+5,289
| +16% | +$416K | 0.43% | 82 |
|
|
2014
Q1 | $2.42M | Buy |
32,062
+3,480
| +12% | +$254K | 0.34% | 86 |
|
|
2013
Q4 | $1.96M | Buy |
28,582
+7,974
| +39% | +$554K | 0.29% | 88 |
|
|
2013
Q3 | $1.42M | Buy |
20,608
+11,212
| +119% | +$742K | 0.23% | 105 |
|
|
2013
Q2 | $595K | Buy |
+9,396
| New | +$611K | 0.3% | 43 |
|
Other funds holding NVS
First Horizon Advisors's NVS Position: Q2 2025 in Review
First Horizon Advisors reduced its Novartis (NVS) stake by 15% in Q2 2025, selling an estimated $255K and leaving 12,677 shares worth $1.53M. The position accounts for 0.04% of the portfolio, ranked #221.
First Horizon Advisors first reported a position in NVS in Q2 2013 and has held it in 49 quarters since. The position peaked at $7.33M in Q4 2020. 1,384 funds tracked by Wall St. Rank hold NVS as of Q2 2025.
- First Horizon Advisors held 12,677 shares of Novartis worth $1.53M as of Q2 2025.
- First Horizon Advisors sold 2,262 Novartis shares in Q2 2025, an estimated $255K.
- Novartis made up 0.04% of First Horizon Advisors's portfolio in Q2 2025, its #221 holding.
- First Horizon Advisors first reported a position in Novartis in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Novartis position peaked at $7.33M in Q4 2020.
- 1,384 funds tracked by Wall St. Rank held Novartis as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.